0000929638-23-001847.txt : 20230627
0000929638-23-001847.hdr.sgml : 20230627
20230627160151
ACCESSION NUMBER: 0000929638-23-001847
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230623
FILED AS OF DATE: 20230627
DATE AS OF CHANGE: 20230627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schlorff Eric
CENTRAL INDEX KEY: 0001949738
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39927
FILM NUMBER: 231047254
MAIL ADDRESS:
STREET 1: C/O SEASTAR MEDICAL, INC.
STREET 2: 3513 BRIGHTON BOULEVARD, SUITE 410
CITY: DENVER
STATE: CO
ZIP: 80216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SeaStar Medical Holding Corp
CENTRAL INDEX KEY: 0001831868
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 853681132
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3513 BRIGHTON BLVD
STREET 2: SUITE 410
CITY: DENVER
STATE: CO
ZIP: 80216
BUSINESS PHONE: 844-427-8100
MAIL ADDRESS:
STREET 1: 3513 BRIGHTON BLVD
STREET 2: SUITE 410
CITY: DENVER
STATE: CO
ZIP: 80216
FORMER COMPANY:
FORMER CONFORMED NAME: LMF Acquisition Opportunities Inc
DATE OF NAME CHANGE: 20201109
4
1
form4.xml
X0407
4
2023-06-23
0001831868
SeaStar Medical Holding Corp
ICU
0001949738
Schlorff Eric
C/O SEASTAR MEDICAL HOLDING CORPORATION
3513 BRIGHTON BLVD., SUITE 410
DENVER
CO
80216
true
true
Chief Executive Officer
false
Common Stock, par value $0.0001 per share
2023-06-23
4
A
0
417386
0
A
682399
D
Stock Option (Right to Buy)
1.84
2033-04-06
Common Stock
99724
99724
D
Stock Option (Right to Buy)
10
2029-03-01
Common Stock
17986
17986
D
Stock Option (Right to Buy)
0.53
2030-02-20
Common Stock
83985
83985
D
Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. Such fully vested shares of common stock are issued as payment for the occurrence of an exit event bonus under that certain Transaction Bonus Agreement, dated as of December 23, 2021, as amended, between the Issuer and the Reporting Person.
Includes 66,483 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.
All options reported herein will vest, subject to continued service, on April 6, 2024.
These options are fully vested.
The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021.
/s/ Eric Schlorff
2023-06-27